AI Slop Is Infiltrating Online Children's Content
Low-quality, mass-produced video content is alarming child development experts. Few guardrails are in place to stop it.
Rifling Through the Evidence: Uncertainty in Firearms Analysis
Recently published studies raise basic methodology questions about the tests used to vet ballistic analysts.
Why Insect Farming Startups Are Going Bankrupt
Despite the initial hype, insect agriculture is facing the economic realities of competing with the traditional meat industry.
Stuck in the Weeds: An Invasive Plant Meets Bureaucracy
At the U.S.-Mexico border and beyond, Arundo donax shouldn’t be hard to control. Red tape and disorder get in the way.
State Bills on Environmental Regulations Raise Burden of Proof
Agencies will have to show a “direct causal link” to “manifest bodily harm,” not just an increased risk of disease.
Why the FDA Is Embracing Old Math for New Drugs
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Under Trump, mRNA Skepticism Threatens a Promising Technology
The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.
Do America's Top Health Research Officials Stick Around Too Long?
Critics argue that NIH directors should have term limits. Others say leadership continuity matters. Who's right?
Few U.S. Doctors Have Seen Measles in Person. That's a Problem.
As the risk of measles mounts, health care workers face an unusual challenge: Many don't know what it looks like.
The Big Questions Surrounding Brain Organoid Research
Scientists are growing brain tissue to learn more about the organ. What will the public make of the work?
Scientia